Abstract
High dose I-131 therapy is administered to thyroid cancer patients after thyroidectomy. In the treatment process when a radiopharmaceutical is administered to patients, they become a mobile source of radiation. After the treatment, contamination may arise from large amount of activity, which is excreted during the period of hospitalization. To reduce the rate of exposure it is essential to monitor workplace. This study determines the rate of radiation exposure in the room where the patient stays during the period of hospitalization as well as the adjacent rooms and surrounding areas. DOI: http://dx.doi.org/10.3329/bjnm.v17i1.22491 Bangladesh J. Nuclear Med. 17(1): 50-54, January 2014
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
